Riboxx develops RNA molecules with unique properties. These molecules are dedicated to the following applications:
- Vaccines: Development of dsRNA molecules that activate innate immunity. These are used as adjuvants for therapeutic vaccines (e.g. against cancer and infections) and prophylactic vaccines (e.g. against infections).
- Oncology & Infections: Development of Toll-like receptor 3 (TLR3) agonists. TLR3 agonists are used in immunotherapy against cancer and/or infectious diseases.
- Gene silencing: Development of customized and tailor-made molecular tools for gene silencing in vitro and in vivo.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Meissner Strasse 191, Radebeul,01445,germany
- Phone
- (490) 351-8336
- in****@****oxx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- riboxx.com
- Keywords
- Therapeutic vaccines, Prophylactic vaccines, Immunoadjuvants, Immunotherapy, Oncology, Gene Silencing.
- HQ
- Radebeul
Riboxx Gmbh Questions
Riboxx Gmbh's helpline number is (490) 351-8336
Riboxx Gmbh's website is riboxx.com
Riboxx Gmbh's LinkedIn profile is https://de.linkedin.com/company/riboxx-gmbh
Riboxx Gmbh has
1 employees.
View email and phone details for 1
employees at Riboxx Gmbh.
Riboxx Gmbh's industry is
Biotechnology Research
Riboxx Gmbh's top competitors are
Zytomanufaktur Dresden Gmbh,
Gress Speditions Gmbh,
Idd Biotech Sa,
Cotectra Gmbh,
Neuron-D Gmbh,
Biosellal,
Riboxx Pharmaceuticals,
Innotere Gmbh,
Biodev,
Histide.
Riboxx Gmbh's support email address is info@riboxx.com
Riboxx Gmbh's categories are Biotechnology Research
Riboxx Gmbh's founding year is 2009
